Hematopoietic recovery in patients receiving chimeric antigen receptor T-cell therapy for hematologic malignancies
Tania Jain(Johns Hopkins University), Sham Mailankody(Memorial Sloan Kettering Cancer Center), Bianca Santomasso(Georgetown University), Yunxin Chen(Memorial Sloan Kettering Cancer Center), Terence J. Purdon(Memorial Sloan Kettering Cancer Center), Gunjan L. Shah(Cornell University), Melody Smith(Memorial Sloan Kettering Cancer Center), Claudia Diamonte(Memorial Sloan Kettering Cancer Center), Craig S. Sauter(Memorial Sloan Kettering Cancer Center), Andrea Knežević(Memorial Sloan Kettering Cancer Center), Sean M. Devlin(Memorial Sloan Kettering Cancer Center), Connie Lee Batlevi(Memorial Sloan Kettering Cancer Center), Michael Scordo(Cornell University), M. Lia Palomba(Memorial Sloan Kettering Cancer Center), Renier J. Brentjens(Roswell Park Comprehensive Cancer Center), Sergio Giralt(Memorial Sloan Kettering Cancer Center), Elizabeth Halton(Memorial Sloan Kettering Cancer Center), Miguel‐Angel Perales(Memorial Sloan Kettering Cancer Center), Eric L. Smith(Dana-Farber Cancer Institute), Jae H. Park(Memorial Sloan Kettering Cancer Center), Elena Mead, Martina Pennisi(University of Milan), Josel D. Ruiz, Molly Maloy(Cornell University)
Cited by 264
Related Papers
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2018|3.7k
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
|Science Translational Medicine|2014|2.5k
CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATION
|British Journal of Haematology|1998|1.5k
Engineering strategies to overcome the current roadblocks in CAR T cell therapy
|Nature Reviews Clinical Oncology|2019|1.4k
Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.
|Journal of Clinical Oncology|1997|1.3k